Skip to main content

Table 1 Commonly used anti-malarial drugs of patients attending St. Mary’s Hospital Lacor, Gulu (information obtained from excluded patients)

From: Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda

Pretreatment drug, n (%)2013
(N = 47)
2014
(N = 96)
2015
(N = 23)
2016
(N = 8)
2017
(N = 7)
Total
(N = 181)
Artemether (intramuscular)1 (2.1)00001 (0.6)
Artesunate (intravenous)02 (2.1)2 (8.7)004 (2.2)
Chloroquine3 (6.4)1 (1.0)0004 (2.2)
Artemether–lumefantrine34 (72.3)67 (69.8)6 (26.1)7 (85.7)6 (85.7)120 (66.3)
Sulfadoxine–pyrimethamine2 (4.3)5 (5.2)1 (4.4)008 (4.4)
Quinine6 (12.8)6 (6.3)1 (4.4)1 (14.3)014 (7.7)
Artesunate and artemether lumefantrine01 (1.0)0001 (0.6)
Artemether–lumefantrine and sulfadoxine–pyrimethamine01 (1.0)0001 (0.6)
Artemether–lumefantrine and quinine03 (3.1)0003 (1.7)
Unknown1 (2.1)10 (10.4)13 (57.0)01 (14.3)25 (13.8)